Literature DB >> 2021956

Induction of lymphokine-activated killer activity in rat splenocyte cultures: the importance of 2-mercaptoethanol and indomethacin.

P J Kuppen1, A M Eggermont, A Marinelli, E de Heer, C J van de Velde, G J Fleuren.   

Abstract

The role of 2-mercaptoethanol and indomethacin in the induction of lymphokine-activated killer (LAK) activity by interleukin-2 (IL-2) in rat splenocyte cultures was investigated. Spleens from 4-month-old male rats of five different strains were tested. Splenocytes were cultured for 3-5 days in the presence of IL-2 (1000 U/ml) and LAK activity was assessed by 4-h 51Cr release assays with P815 and YAC-1 cells as targets. LAK activity could be induced by IL-2 in splenocytes from all rat strains, but only when 2-mercaptoethanol was present in the culture medium. Optimal LAK activity was induced when the 2-mercaptoethanol concentration in splenocyte cultures was at least 5 microM. Different rat strains showed differences in levels of in vitro induction of LAK activity. In the presence of 2-mercaptoethanol the level of LAK activity induced by IL-2 was high in BN and Lewis rats, intermediate in Wistar and Wag rats, and low in DZB rats. In the absence of 2-mercaptoethanol no or minimal LAK activity was induced. Furthermore we observed that addition of 50 microns indomethacin to the culture medium in the presence of 2-mercaptoethanol augmented the induction of LAK activity to some extent. In the absence of 2-mercaptoethanol, addition of indomethacin resulted only in low levels or no induction of LAK activity. We conclude that for optimal induction of LAK activity by IL-2 in rat splenocyte cultures 2-mercaptoethanol is essential, while indomethacin can only marginally further improve this induction.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2021956     DOI: 10.1007/bf01742524

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  32 in total

1.  Immune responses in vitro. IV. A comparison of the protein-free and mouse serum-supplemented mouse mixed lymphocyte interaction assays.

Authors:  A B Peck; E Katz-Heber; R E Click
Journal:  Eur J Immunol       Date:  1973-08       Impact factor: 5.532

2.  Pharmacologic modulation of arachidonic acid metabolism in man. A minireview with emphasis on radioimmunological methods used to quantitate drug effects.

Authors:  C Patrono; P Patrignani
Journal:  Int J Immunopharmacol       Date:  1982

3.  Role of mercaptoethanol and endotoxin in stimulating B lymphocyte colony formation in vitro.

Authors:  D Metcalf
Journal:  J Immunol       Date:  1976-03       Impact factor: 5.422

4.  Function of 2-mercaptoethanol as a macrophage substitute in the primary immune response in vitro.

Authors:  H Lemke; H G Opitz
Journal:  J Immunol       Date:  1976-08       Impact factor: 5.422

5.  The effects of mercaptoethanol and of peritoneal macrophages on the antibody-forming capacity of nonadherent mouse spleen cells in vitro.

Authors:  C Chen; J G Hirsch
Journal:  J Exp Med       Date:  1972-09-01       Impact factor: 14.307

6.  Generation of lymphokine-activated killer cell activity from non-NK precursor cells.

Authors:  F J Ramsdell; R A Lindemann; H Y Shau; J D Gray; S H Golub
Journal:  Cell Immunol       Date:  1988-10-15       Impact factor: 4.868

7.  Mechanism of augmentation of the antibody response in vitro by 2-mercaptoethanol in murine lymphocytes. II. A major role of the mixed disulfide between 2-mercaptoethanol and cysteine.

Authors:  H Ohmori; I Yamamoto
Journal:  Cell Immunol       Date:  1983-07-01       Impact factor: 4.868

8.  Adoptive immunotherapy of established pulmonary metastases with LAK cells and recombinant interleukin-2.

Authors:  J J Mulé; S Shu; S L Schwarz; S A Rosenberg
Journal:  Science       Date:  1984-09-28       Impact factor: 47.728

9.  Lymphokine-activated killer cells in rats: analysis of progenitor and effector cell phenotype and relationship to natural killer cells.

Authors:  N L Vujanovic; R B Herberman; M W Olszowy; D V Cramer; R R Salup; C W Reynolds; J C Hiserodt
Journal:  Cancer Res       Date:  1988-02-15       Impact factor: 12.701

10.  Lymphokine-activated killer cells in rats: analysis of tissue and strain distribution, ontogeny, and target specificity.

Authors:  N L Vujanovic; R B Herberman; J C Hiserodt
Journal:  Cancer Res       Date:  1988-02-15       Impact factor: 12.701

View more
  3 in total

1.  Soluble factors produced by macrophages/monocytes inhibit lymphokine-activated killer activity in rat splenocyte cultures.

Authors:  P J Kuppen; A M Eggermont; R B Quak; A Marinelli; C J van de Velde; G J Fleuren
Journal:  Cancer Immunol Immunother       Date:  1994-01       Impact factor: 6.968

2.  The development and purification of a bispecific antibody for lymphokine-activated killer cell targeting against the rat colon carcinoma CC531.

Authors:  P J Kuppen; A M Eggermont; K M Smits; J D van Eendenburg; S P Lazeroms; C J van de Velde; G J Fleuren
Journal:  Cancer Immunol Immunother       Date:  1993-06       Impact factor: 6.968

Review 3.  Review: 2-mercaptoethanol alteration of in vitro immune functions of species other than murine.

Authors:  Robert E Click
Journal:  J Immunol Methods       Date:  2013-11-22       Impact factor: 2.303

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.